Skip to main content

Medical Diagnostics Patenting Faces Increased Challenges in Canada

August 11, 2016

In the August/September issue of Biotechnology Focus Magazine, Melanie Szweras and Carmela De Luca discuss recent changes in patent office examination policy which may have negative long term impacts on the innovative diagnostics industry in Canada.

To read the article click here.

Content shared on Bereskin & Parr’s website is for information purposes only. It should not be taken as legal or professional advice. To obtain such advice, please contact a Bereskin & Parr LLP professional. We will be pleased to help you.

Author(s):

Melanie Szweras Melanie Szweras
B.Sc., Ph.D. (Genetics), LL.B.
Partner
416.957.1678  email Melanie Szweras
Carmela De Luca Carmela De Luca
B.Sc. (Hons. Biochem., Co-op), Ph.D. (Exp. Med.), J.D.
Partner
514.871.2929  email Carmela De Luca